JEONJINBIO (110020) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, JEONJINBIO (110020) reported revenue of 13.7 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202513.7 billion KRW-343 million KRW-196 million KRW[source]
202419.3 billion KRW1.2 billion KRW4.3 billion KRW[source]
202315.7 billion KRW-1.2 billion KRW-6.4 billion KRW[source]
20227.8 billion KRW-3.2 billion KRW-3.2 billion KRW[source]
20213.2 billion KRW-3.0 billion KRW-2.1 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202518.5 billion KRW1.1 billion KRW17.4 billion KRW[source]
202418.9 billion KRW1.2 billion KRW17.7 billion KRW[source]
202317.7 billion KRW11.5 billion KRW6.2 billion KRW[source]
202217.9 billion KRW8.4 billion KRW9.5 billion KRW[source]
202124.8 billion KRW14.0 billion KRW10.8 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice